Accepted at 5:44 p.m. Dec, 26, 2024 by mohannadkh10
Author: mohannadkh10
Related Note: 1489966943274
Rationale for change

The presentation of the question is obliterative vasculopathy due to long term use
Source: UWorld - Step 1 6678

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::^EXPN #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::03_Sirolimus_(Rapamycin) #AK_Step2_v12::#UWorld::Step::3980 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Tacrolimus #AK_Step1_v12::#UWorld::Step::6678 #AK_Step2_v12::#UWorld::Step::16485 #AK_Step2_v12::#SketchyIM::04_Nephrology_&_Urology::05_Retired_Lessons::01_AKI_SOAP_[OLD_VERSION] #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::03_Immunosuppressants #AK_Step2_v12::#Resources_by_rotation::IM::uw::#misc_dorian #AK_Step2_v12::#SketchyIM::04_Nephrology_&_Urology::02_Acute_Kidney_Injury::02_Pre-Renal_AKI #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::02_Tacrolimus #AK_Step2_v12::#AMBOSS::fF0kh3 #AK_Step1_v12::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::Transplant-Rejection-Prophylaxis #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Cyclosporine #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::12_Drug_reactions-multiorgan #AK_Step1_v12::#AMBOSS::IlaYyk #AK_Step1_v12::#UWorld::Step::14967 #AK_Step1_v12::#Bootcamp::Microbiology::37_Antifungals::03_Allylamines,_Echinocandins,_and_Polyenes #AK_Step1_v12::#OME::03_Immune::01_Immunology::16_Immunosuppression #AK_Step1_v12::#B&B::13_Immunology::03_Pharm::02_Immunosuppressive_Drugs #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step3_v12::#UWorld::5673 #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::07_Immunosuppressants #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::02_Secondary_Hypertension #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::Original_decks::Dorian::im::uw::miscellaneous #AK_Step1_v12::#OME::PreClinical::03_Immune::01_Immunology::16_Immunosuppression #AK_Step2_v12::#SketchyIM::06_Electrolytes_&_Acid_Base::04_Retired_Lessons::03_Hyperkalemia_Ddx_&_Management_[OLD_VERSION] #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::11_Pathology::01_Cardiac_Pathology::02_Hypertension #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#UWorld::COMLEX::100772 #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::02_Tacrolimus #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#UWorld::COMLEX::103492 #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::01_Cyclosporine #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::01_Cyclosporine #AK_Step1_v12::#UWorld::COMLEX::26049 #AK_Step1_v12::#AMBOSS